Source: OINDPnews

AAHI: AAHI gets $3 million for development of antiviral nasal spray

The non-profit Access to Advanced Health Institute (formerly the Infectious Disease Research Institute) said that it has received an award of up to $3 million for development of a prototype antiviral nasal spray from the US Department of Defense (D0D). The news comes soon after AAHI announced that it had received an award of worth [...]

Read full article »

AAHI's Competitors | AAHI's News | AAHI's Financials

Followers on Owler

Est. Annual Revenue

$25-100M

Est. Employees

25-100

President & CEO

Corey Casper

CEO Approval Rating

90/100

AAHI is a Washington-based nonprofit biotech research institute that develops and manufactures vaccines and immunotherapies for the treatment of infectious diseases.